ACM
ETNB

ADAR1 Capital Management’s 89bio ETNB Stock Holding History

ADAR1 Capital Management’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,113,153
Closed -$31.1M – 276
2025
Q3 		$31.1M Buy
2,113,153
+1,237,170
+141% +$12.6M 2.92% 8
2025
Q2 		$8.6M Buy
875,983
+71,763
+9% +$594K 1.32% 17
2025
Q1 		$5.85M Buy
804,220
+289,082
+56% +$2.53M 1.09% 26
2024
Q4 		$4.03M Buy
515,138
+508,578
+7,753% +$4.19M 0.81% 31
2024
Q3 		$48.5K Buy
6,560
+1,000
+18% +$8.41K 0.01% 217
2024
Q2 		$44.5K Buy
5,560
+2,500
+82% +$22.3K 0.01% 193
2024
Q1 		$35.6K Buy
3,060
+2,630
+612% +$29.1K 0.01% 199
2023
Q4 		$4.8K Buy
+430
New +$3.95K ﹤0.01% 146

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

ADAR1 Capital Management's ETNB Position: Q4 2025 in Review

ADAR1 Capital Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 2,113,153 shares — an estimated $31.1M sold.

ADAR1 Capital Management first reported a position in ETNB in Q4 2023 and held it in 8 quarters. The position peaked at $31.1M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • ADAR1 Capital Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • ADAR1 Capital Management sold 2,113,153 89bio shares in Q4 2025, an estimated $31.1M.
  • ADAR1 Capital Management first reported a position in 89bio in Q4 2023 and held it in 8 quarters.
  • ADAR1 Capital Management's 89bio position peaked at $31.1M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on ADAR1 Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.